Rituximab administration prior to immune tolerance induction improves immune tolerance outcome in hemophilia patients with factor VIII Inhibitors

被引：0
|
作者：
Almomen, A. M. [2 ]
Hasanato, R. [1 ]
Afzal, A. [1 ]
Alsaleh, K. [2 ]
机构：
[1] King Saud Univ, Riyadh, Saudi Arabia
[2] King Saud Univ, Ctr Excellence Thrombosis & Hemostasis, Riyadh, Saudi Arabia
来源：
HAEMOPHILIA | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [31] Immune Tolerance Induction in Severe Hemophilia a Patients Using Wilate, a Von Willebrand Factor/Factor VIII Concentrate
    Wu, John K.
    Woo, Celina
    Crilly, Erica
    BLOOD, 2014, 124 (21)
  • [32] Immune tolerance induction in hemophilia a patients with inhibitors by treatment with recombinant factor VIII (in fact): a retrospective non-interventional study
    Rivard, G. E.
    Rothschild, C.
    Toll, T.
    Achilles, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 118 - 119
  • [33] Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A
    Evans, GL
    Morgan, RA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (10) : 5734 - 5739
  • [34] Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A
    Madoiwa, S
    Yamauchi, T
    Hakamata, Y
    Kobayashi, E
    Arai, M
    Sugo, T
    Mimuro, J
    Sakata, Y
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (05) : 754 - 762
  • [35] Combined anti-CD20 and mTOR inhibition with factor VIII for immune tolerance induction in hemophilia A patients with refractory inhibitors
    Doshi, Bhavya S.
    Raffini, Leslie J.
    George, Lindsey A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (04) : 848 - 852
  • [36] Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A
    Sherman, Alexandra
    Biswas, Moanaro
    Herzog, Roland W.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [37] Factor VIII gene (F8) mutations as a predictor of outcome in immune tolerance induction (ITI) in hemophilia A patients with high-responding inhibitors
    Coppola, A.
    Margaglione, M.
    Santagostino, E.
    Rocino, A.
    Scaraggi, F.
    Tagliaferri, A.
    Castaman, G.
    Messina, M.
    Mancuso, M. E.
    Iorio, A.
    Schinco, P.
    Zanon, E.
    Musso, R.
    Mancuso, G.
    Di Minno, G.
    Mannucci, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 191 - 192
  • [38] Experience with a third generation recombinant factor VIII concentrate (Advate®) for immune tolerance induction in patients with hemophilia A
    Valentino, L.
    Recht, M.
    Dipaola, J.
    Shapiro, A.
    Pipe, S.
    Ewing, N.
    Urgo, J.
    Bullock, T.
    Simmons, M.
    Pipe, R.
    Deguzman, C.
    HAEMOPHILIA, 2008, 14 : 16 - 16
  • [39] Treatment of Haemophilia a (HA) Patients with Inhibitors: Immune Tolerance Induction with a Single Factor VIII/Von Willebrand Factor Concentrate in an Observational Immune Tolerance Induction Study (ObsITI)
    Ettingshausen, C. Escuriola
    Berntorp, Erik
    Dargaud, Yesim
    Gutowski, Zeynep
    Negrier, Claude
    Pavlova, Anna
    Oldenburg, Johannes
    BLOOD, 2018, 132
  • [40] Induction of factor VIII tolerance by hemophilia gene transfer to eradicate factor VIII inhibitors
    Young, Guy
    BLOOD ADVANCES, 2025, 9 (02) : 265 - 269
12345